The events of the last 24 hours have made the Oxford / AstraZeneca vaccine truly safe and concerned.
A quick recap:
After days of speculative media coverage, European drug regulators on Wednesday confirmed a possible link between the Oxford-AstraZeneca vaccine and rare blood clots, and UK officials recommended that people under 30 receive alternative vaccines needed.
While the European Medicines Agency and its British counterpart acknowledged that mounting evidence pointed to a link, they both emphasized that the possibility of clotting was still very low and that the vaccine was still very effective at preventing Kovid-19. Was.
The EMA’s decision was based on 62 cases of clotting in the blood-draining sinus and 24 cases of clotting in the stomach. The cases were reported in the European Union database of European countries, including Britain, where about 25 million people have received the vaccine.
The European regulator advised that the vaccine was still commonly used, while the UK advised that people under 30 should receive a different vaccine. The reason for this is that as the age group gets younger, Kovid-19 decreases the likelihood of serious illness or death, which means the difference between benefits and risks.
The British government is already fighting in the hope that Wednesday’s news will not hesitate about the vaccine. Britain’s Health Secretary Matt Hancock this morning sought to reassure Britain’s people that the vaccine rollout was “in the safest possible way”.
“Be assured of the fact that we are taking precautions,” Hancock told Sky News on Thursday. “All three vaccines used in the UK are safe, and they are safe at all ages. But there is a preference for the under-30s, if they want Pfizer or Modern Jab instead. ”
The Daily Telegraph Newspaper Even met a person’s family and talked Those who died of a blood clot after being vaccinated said they still believe people should take the jab if given a chance.
This story, of course, has implications beyond Britain, and development in the coming days will be very important in the global fight against coronoviruses. Many developing countries rely on the AstraZeneca vaccine as a way to prevent the epidemic.